1. Home
  2. UAMY vs IRIX Comparison

UAMY vs IRIX Comparison

Compare UAMY & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

HOLD

Current Price

$4.63

Market Cap

955.8M

Sector

Industrials

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.64

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAMY
IRIX
Founded
1968
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
955.8M
15.0M
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
UAMY
IRIX
Price
$4.63
$0.64
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$9.44
N/A
AVG Volume (30 Days)
6.2M
96.5K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.85
EPS
N/A
N/A
Revenue
$39,257,708.00
$41,593,000.00
Revenue This Year
$219.89
$3.07
Revenue Next Year
$104.28
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
162.80
N/A
52 Week Low
$4.36
$0.65
52 Week High
$19.71
$1.65

Technical Indicators

Market Signals
Indicator
UAMY
IRIX
Relative Strength Index (RSI) 41.33 24.59
Support Level $4.48 N/A
Resistance Level $5.78 $0.98
Average True Range (ATR) 0.33 0.03
MACD 0.01 -0.00
Stochastic Oscillator 10.45 14.37

Price Performance

Historical Comparison
UAMY
IRIX

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: